AI assistant
Iterum Therapeutics plc — Director's Dealing 2018
May 29, 2018
34796_dirs_2018-05-29_24755d45-1e7a-47af-b40b-32926866b5b7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Iterum Therapeutics plc (ITRM)
CIK: 0001659323
Period of Report: 2018-05-24
Reporting Person: Schaffnit Jeffrey R. (Chief Commercial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-05-24 | Stock Option (Right to Buy) | $13.00 | A | 25461 | Acquired | 2028-05-23 | Ordinary Shares (25461) | Direct |
| 2018-05-24 | Stock Option (Right to Buy) | $13.00 | A | 6365 | Acquired | 2028-05-23 | Ordinary Shares (6365) | Direct |
Footnotes
F1: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of February 19, 2018 (the "Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date.
F2: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of May 24, 2018 (the "Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date.